HIV 1 News and Research

RSS

Hepatitis C affects so many people and yet not recognized as serious public health problem

May is Hepatitis Awareness Month, and you may find it surprising to learn an estimated 4 million Americans have been infected with Hepatitis C. This silent disease is three to five times more prevalent than HIV. Hepatitis C is the most common cause of liver transplants in the U.S.

21 May 2010

Media examines recent Oxfam report on impact of aid to developing countries

In a recent report, Oxfam "outlines how aid has contributed to economic growth in poor countries by getting 33 million more children into school, boosting access to HIV drugs tenfold, funding tens of millions of anti-malaria bed nets, and building up health services," Reuters AlertNet reports (Rowling, 5/20).

21 May 2010

COTI reports positive results from first phase of HIV integrase inhibitor discovery program

Critical Outcome Technologies Inc. today announced positive results from the first phase of its HIV integrase inhibitor discovery program. These results provide novel intellectual property to the Company and further validation of the CHEMSAS® drug discovery technology.

21 May 2010

WHA addresses counterfeit medicines

Discussions about combatting counterfeit medicines continued at the 63rd World Health Assembly (WHA) in Geneva on Wednesday, Agence France-Press reports

21 May 2010

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is spotlighted on an interactive map posted on the website of Inc. magazine.

20 May 2010

Research and movement in future towards universal influenza virus vaccine

Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.

20 May 2010

New IRMA report outlines the growing field of rectal microbicide R&D

International Rectal Microbicide Advocates will officially release its third landmark report -- "From Promise to Product: Advancing Rectal Microbicide Research and Advocacy" -- at the 2010 International Microbicides Conference in Pittsburgh, PA taking place May 22-25, 2010.

20 May 2010

Dynamic testing approach for HIV/AIDS diagnostics

A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.

20 May 2010

Public health and HIV/AIDS prevention policies should reflect and work with evolution of sexual behavior

HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.

20 May 2010

Nearly 1 in 5 cases of infection with C. neoformans caused by multiple strains of pathogen: Research

New research shows that nearly 1 in 5 cases of infection with the potentially deadly fungus Cryptococcus neoformans are caused by not one but multiple strains of the pathogen. Researchers from the Institut Pasteur and the University of Minnesota Medical School report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.

20 May 2010

Global Fund launches campaign to generate public support for preventing mother-to-child transmission of HIV

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a campaign to generate public support for efforts to eliminate mother-to-child transmission of HIV by 2015, the BBC reports. "The Born HIV Free campaign comes at a critical time, with the fund seeking donations of up to $20bn over the next three years," the BBC continues.

20 May 2010

World Health Assembly news

Media outlets continue to track news emerging from the 63rd annual World Health Assembly (WHA) in Geneva.

20 May 2010

New U.N. efforts aim to help Haitians obtain 'secure housing'

"The head of the U.N. mission in Haiti Edmond Mulet unveiled new efforts Tuesday to provide secure housing to thousands of people made homeless by January's devastating earthquake," Agence France-Presse reports.

20 May 2010

2010 funding program for Inova Life Sciences - George Mason University research collaboration open

What do you get when you mix a world-class health system with an innovative, entrepreneurial university? A very successful research collaboration.

20 May 2010

Lancet special series examines TB worldwide

The Lancet released on Wednesday a special series on tuberculosis, which includes a series of papers and comments highlighting the need for new tools, the threat posed by drug-resistant strains, results of current control efforts and other issues about TB worldwide, Agence France-Presse reports.

20 May 2010

Fraud and abuse cases come to conclusions

Los Angeles Times: "A man who recruited destitute HIV patients to be straw purchasers in a prescription drug scheme was convicted by a federal jury Tuesday in Los Angeles. Nathaniel Newhouse, 53, showed no expression as the verdict was read in the courtroom of U.S. District Judge Dean D. Pregerson." Newhouse was caught with 29 bottles of powerful painkillers two years ago. Investigators said they had a street value of up to $80,000. HIV patients arranged for doctors to prescribe the drugs, which were passed on to Newhouse (Glover, 5/19).

20 May 2010

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

First Edition: May 19, 2010

Today's headlines highlight issues related to the federal debt, developments regarding the Medicare physician payment fix and news from the states.

19 May 2010

Experts accelerate discovery and development of new TB drugs: Lancet article

According to a paper published today in the Lancet, there is unprecedented progress in the development of the global tuberculosis drug pipeline with 10 drug candidates currently in clinical development. The paper was written by a team of renowned international experts led by Zhenkun Ma, Ph.D., Chief Scientific Officer for the TB Alliance, a not-for-profit organization accelerating the discovery and development of new TB drugs.

19 May 2010

AP examines HIV microbicides, prep research

"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.

19 May 2010